DNA sensing via the cGAS/STING pathway activates the immunoproteasome and adaptive T‐cell immunity

Xinyuan Wang,Huabin Zhang,Yuqin Wang,Laylan Bramasole,Kai Guo,Fatima Mourtada,Thomas Meul,Qianjiang Hu,Valeria Viteri,Ilona Kammerl,Melanie Konigshoff,Mareike Lehmann,Thomas Magg,Fabian Hauck,Isis E Fernandez,Silke Meiners
DOI: https://doi.org/10.15252/embj.2022110597
2023-03-15
The EMBO Journal
Abstract:The DNA‐sensing cGAS/STING pathway regulates immunoproteasome function and MHC class I antigen presentation to promote T‐cell activation that may underlie pathology of idiopathic pulmonary fibrosis. The immunoproteasome is a specialized type of proteasome involved in MHC class I antigen presentation, antiviral adaptive immunity, autoimmunity, and is also part of a broader response to stress. Whether the immunoproteasome is regulated by DNA stress, however, is not known. We here demonstrate that mitochondrial DNA stress upregulates the immunoproteasome and MHC class I antigen presentation pathway via cGAS/STING/type I interferon signaling resulting in cell autonomous activation of CD8+ T cells. The cGAS/STING‐induced adaptive immune response is also observed in response to genomic DNA and is conserved in epithelial and mesenchymal cells of mice and men. In patients with idiopathic pulmonary fibrosis, chronic activation of the cGAS/STING‐induced adaptive immune response in aberrant lung epithelial cells concurs with CD8+ T‐cell activation in diseased lungs. Genetic depletion of the immunoproteasome and specific immunoproteasome inhibitors counteract DNA stress induced cytotoxic CD8+ T‐cell activation. Our data thus unravel cytoplasmic DNA sensing via the cGAS/STING pathway as an activator of the immunoproteasome and CD8+ T cells. This represents a novel potential pathomechanism for pulmonary fibrosis that opens new therapeutic perspectives.
What problem does this paper attempt to address?